%20(1).png)
Richardson fungal infections diagnosis and management 3ed 2003 | Download Book Pdf
In the six years that have elapsed since the second edition of this book was published, there have been a number of significant developments in the diagnosis and management of fungal infections. In developed countries, the introduction of combination antiretroviral treatment regimens has led to a marked reduction in the incidence of opportunistic fungal infections among persons with the acquired immunodeficiency syndrome (AIDS). In contrast, in countries where these drugs are unavailable,
the burden of these diseases is large and increasing. Other developments in medical practice that have led to significant changes in the incidence of fungal infections include the increasing use of aggressive therapeutic technologies in intensive care units, novel immunosuppressive regimens among patients undergoing transplants or treatment for malignancies, the increasing use of azole antifungal agents for chemoprophylaxis, and the widespread use of amphotericin B for empirical treatment. In many instances, these developments have resulted in improved survival of individuals with life-threatening illnesses, but some have also contributed to the emergence of new populations at risk for fungal infections.
Richardson fungal infections diagnosis and management 3ed 2003
We have tried to include as many of these developments as possible without, we hope, confusing what is intended to be a concise introduction to the subject. For this edition, the general format of the book has been retained, but extensive revision has been undertaken, and separate sections on epidemiology and prevention have been added to most of the chapters. Another feature we have introduced is a short list of further reading at the end of each chapter. These lists are not by themselves all-embracing, but rather are intended to highlight some of the most important papers that we have drawn upon for the information provided in the text.
Richardson fungal infections diagnosis and management 3ed 2003
We have made every effort to ensure that our drug and dosage recommendations are accurate and in agreement with current guidelines. It should be noted that the formulations and usages of the different drugs described do not necessarily have the specific approval of the regulatory authorities of all countries. Because dosage regimens can be modified in the light of new clinical
research findings, readers are advised to check the manufacturers’ prescribing information to see whether
changes have been made in the recommended dosages, or whether additional contraindications for use have been introduced.
Richardson fungal infections diagnosis and management 3ed 2003
0 Comments